http://biz.yahoo.com/ic/news/515.htmlThe latest news on the Biotechnology industry from Yahoo! Financeen-usSat, 7 Nov 2009 19:05:07 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12glbshkc/*http%3A//twincities.bizjournals.com/twincities/stories/2009/11/02/daily62.html?ana=yfcpcyahoo_finance/3146046810Sat, 7 Nov 2009 19:05:07 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091107/20091107005004.html?.v=1CAMBRIDGE, Mass.----An analysis demonstrating the ability of DX-88 to resolve symptoms of acute hereditary angioedema attacks in all anatomic locations and to sustain effect will be presented in an oral presentation this week at the American College of Allergy, Asthma and Immunology 2009 Annual Meeting in Miami Beach.yahoo_finance/1072717122Sat, 7 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11hrpvdi4/*http%3A//www.cnbc.com/id/33728742/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/3445240142Sat, 7 Nov 2009 02:46:23 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005957.html?.v=1SAN DIEGO----Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 compared to subcutaneous injection of lispro alone.yahoo_finance/2849369729Sat, 7 Nov 2009 02:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005972.html?.v=1LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.----GlaxoSmithKline and XenoPort, Inc. today announced that the U.S. Food and Drug Administration has extended the original Prescription Drug User Fee Act goal date for its review of the New Drug Application for GSK1838262/XP13512 to February 9, 2010.yahoo_finance/804402986Sat, 7 Nov 2009 01:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11h1q2t67/*http%3A//www.cnbc.com/id/33728388/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/2518014574Sat, 7 Nov 2009 00:58:37 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/cnbc/rss/SIG=113mb0hsu/*http%3A//www.cnbc.com/id/15840232?play=1&video=1321709046&__source=yahoo%7Cheadline%7Cquote%7Cvideo%7C&par=yahooyahoo_finance/2512330842Fri, 6 Nov 2009 23:45:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13fff5gu6/*http%3A//www.thestreet.com/_yahoo/story/10623354/1/cramers-mad-money-recap-next-weeks-game-plan-update-2.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/200192362Fri, 6 Nov 2009 23:32:15 Etc/GMThttp://us.rd.yahoo.com/finance/external/forbes/rss/SIG=1307civ2v/*http%3A//www.forbes.com/2009/11/06/philips-health-care-intelligent-technology-kleisterlee.html?partner=yahootixyahoo_finance/2694564238Fri, 6 Nov 2009 23:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12a26i4vl/*http%3A//seattle.bizjournals.com/seattle/stories/2009/11/02/daily49.html?ana=yfcpcyahoo_finance/4133559535Fri, 6 Nov 2009 22:05:18 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005443.html?.v=1SUMMIT, N.J.----Celgene Corporation today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com.yahoo_finance/3393539103Fri, 6 Nov 2009 21:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005817.html?.v=1NEW YORK----Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Trimeris, Inc. for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Trimeris Board of Directors to sell all of the Company’s outstanding shares of common stock at a price of $3.60 per share to Arigene Co., Ltd. .yahoo_finance/1605054740Fri, 6 Nov 2009 20:09:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091106/177818.html?.v=1TORONTO -- Transition Therapeutics Inc. will hold a conference call on Tuesday, November 10, 2009 at 4:30 P.M. EST to discuss First Quarter fiscal 2010 financial results. Dr. Tony Cruz, Chairman and Chief Executive Officer of the Company, will host the call.yahoo_finance/3755191233Fri, 6 Nov 2009 20:06:05 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=13585n4tr/*http%3A//seekingalpha.com/article/171883-halozyme-therapeutics-inc-q3-2009-earnings-call-transcript?source=yahooyahoo_finance/1993240283Fri, 6 Nov 2009 19:59:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12laufvru/*http%3A//www.marketwatch.com/news/story/drug-stocks-edge-higher-alkermes/story.aspx?guid=%7B6CC0BA14%2D29C3%2D4D7D%2DB5C2%2D154DDB5E40E1%7D&siteid=yhoofDrug stocks gain while shares of Alkermes Inc. fall after the company issues its fiscal second-quarter earnings report and lowers its financial forecast.yahoo_finance/4229570092Fri, 6 Nov 2009 19:38:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091106/177813.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today reported financial results and operational updates for the first fiscal quarter ended September 30, 2009.yahoo_finance/815185290Fri, 6 Nov 2009 18:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091106/ny06895.html?.v=1BioSpecifics Technologies Corp. , a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009.yahoo_finance/968867827Fri, 6 Nov 2009 18:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005662.html?.v=1LOS ANGELES----BioMedReports.com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that one of several expected key news developments has been announced by CEL-SCI Corporation , today.yahoo_finance/805303110Fri, 6 Nov 2009 17:34:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12888gd35/*http%3A//boston.bizjournals.com/boston/stories/2009/11/02/daily60.html?ana=yfcpcyahoo_finance/1380098939Fri, 6 Nov 2009 17:05:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091106/us_earns_halozyme.html?.v=2Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.yahoo_finance/4157500317Fri, 6 Nov 2009 16:21:13 Etc/GMT